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Abstract. 
 
Lamina-associated polypeptide 2 (LAP2) is 
an integral membrane protein of the inner nuclear 
membrane that binds to both lamin B and chromatin 
and has a putative role in nuclear envelope (NE) orga-
nization. We found that microinjection of a recombi-
nant polypeptide comprising the nucleoplasmic domain 
of rat LAP2 (residues 1–398) into metaphase HeLa 
cells does not affect the reassembly of transport-com-
petent nuclei containing NEs and lamina, but strongly 
inhibits nuclear volume increase. This effect appears to 
be specifically due to lamin binding, because it also is 
caused by microinjection of the minimal lamin-binding 
region of LAP2 (residues 298–373) but not by the chro-
matin-binding domain (residues 1–88). Injection of the 
lamin-binding region of rat LAP2 into early G1 phase 
HeLa cells also strongly affects nuclear growth; it al-
most completely prevents the threefold nuclear volume 
increase that normally occurs during the ensuing 10 h. 
Moreover, injection of the fragment during early G1 
phase strongly inhibits entry of cells into S phase, 
whereas injection during S phase has no apparent effect 
on ongoing DNA replication. Since the lamin-binding 
fragment of LAP2 most likely acts by inhibiting dynam-
ics of the nuclear lamina, our results suggest that a nor-
mal function of LAP2 involves regulation of nuclear 
lamina growth. These data also suggest that lamina dy-
namics are required for growth of the NE and for nu-
clear volume increase during the cell cycle, and that 
progression into S phase is dependent on the acquisi-
tion of a certain nuclear volume.
 
T
 
he 
 
nuclear lamina, which is a filamentous protein
meshwork lining the inner nuclear membrane, is
thought to provide a structural framework for the
nuclear envelope (NE)
 
1
 
 and an anchoring site for chroma-
tin at the nuclear periphery (for review see Nigg, 1992;
Georgatos et al., 1994). The lamina consists of a polymeric
assembly of intermediate-type filament proteins (nuclear
lamins) and a number of more minor lamina-associated
polypeptides (LAPs). Four major lamin isotypes (A, B
 
1
 
,
B
 
2
 
, and C) are present in mammalian cells (for review see
Nigg, 1992). B lamins are expressed throughout develop-
ment, whereas A lamins appear at about the time of termi-
nal differentiation, or after it. Three lamina-associated poly-
peptides have been characterized in detail in mammalian
cells: LAP1, LAP2, and a protein called the lamin B recep-
tor (LBR) (for review see Gerace and Foisner, 1994). All
three polypeptides are integral membrane proteins that di-
rectly bind to lamins. LAP2 (Foisner and Gerace, 1993)
and LBR (Worman et al., 1988) preferentially interact with
lamin B, whereas LAP1 (Foisner and Gerace, 1993) inter-
acts with both A and B lamin isotypes. LAP1 (Martin et al.,
1995) and LAP2 (Furukawa et al., 1995) each have a large
nucleoplasmic domain and a single predicted membrane-
spanning segment, whereas LBR (Worman et al., 1990) has
eight predicted membrane-spanning segments and con-
tains a large region with homology to sterol C14 reductase
of 
 
Saccharomyces cerevisiae
 
 (see Georgatos et al., 1994).
The primary transcript of the LAP2 gene is alternatively
spliced (Harris et al., 1994, 1995; Berger et al., 1996) and
gives rise to at least three different proteins: thymopoie-
tins 
 
a
 
, 
 
b
 
 (LAP2), and 
 
g
 
 (Harris et al., 1995). Thymopoietin
 
a
 
 is identical to LAP2 only for the first 187 amino acids, and
lacks an apparent membrane-spanning domain; whereas
thymopoietin 
 
g
 
 contains a deletion of 109 amino acids in
the equivalent of the nucleoplasmic domain of LAP2 (Har-
ris et al., 1995).
It is likely that the attachment of the nuclear lamina to
the inner nuclear membrane is due, at least in part, to the
association of lamins with certain integral membrane pro-
teins of the inner nuclear membrane (Gerace and Foisner,
1994). Lipid modification (farnesylation) of B lamins (Nigg,
1992) also may be important for nuclear membrane at-
tachment. Integral proteins of the inner nuclear mem-
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brane also could have a role in modulating the structure of
lamin filaments (e.g., filament width) and/or in regulating
the growth of the lamina that occurs during interphase in
cycling cells (Gerace and Foisner, 1994). However, which
integral proteins are involved in lamina binding to the in-
ner nuclear membrane or in lamina structure has not been
determined by functional studies.
The association of the nuclear lamina with chromatin is
suggested to involve both nuclear lamins and lamina-asso-
ciated polypeptides. In vitro binding studies show that
lamins can interact with various chromatin substrates (Burke,
1990; Glass and Gerace, 1990; Hoger et al., 1991; Yuan et al.,
1991; Taniura et al., 1995). Quantitative binding analysis
has shown that the COOH-terminal tail domains of lamins
directly associate with isolated rat liver chromatin with ap-
parent 
 
K
 
d
 
s of 
 
z
 
100–300 nM, and interact specifically with
core histones (Taniura et al., 1995). Purified LAP2 associ-
ates with chromosomes isolated from mitotic cells, and its
binding to both lamins and chromosomes is negatively reg-
ulated by mitotic LAP2 phosphorylation (Foisner and Ger-
ace, 1993). LBR, which interacts with the heterochromatin
protein HP1 (Ye and Worman, 1996), has been suggested
to be an additional chromatin-binding component of the
lamina (Pyrpasopoulou et al., 1996; Ye and Worman, 1996).
LBR undergoes mitosis-specific phosphorylation (Courva-
lin et al., 1992; Nikolakaki et al., 1997), but whether this af-
fects HP1 or lamin binding is unknown. The chromatin-bind-
ing properties of these lamina components could reflect an
involvement in a number of possible functions: reassembly
of the NE at the end of mitosis (see below), anchoring of
higher order chromatin domains to the NE during inter-
phase, and regulation of specific interphase chromatin ac-
tivities such as DNA replication (Gerace and Foisner, 1994).
There are several ways in which the lamina might be
linked to regulation of NE structure during mitosis and in-
terphase. During mitosis in higher eukaryotic cells, the NE
is disassembled and lamins are depolymerized (for review
see Nigg, 1992). Concomitantly, integral membrane pro-
teins of the NE become dispersed throughout ER mem-
branes (Yang et al., 1997). Disassembly of the lamina is
likely to be a prerequisite for nuclear membrane disassem-
bly. The reassembly of nuclear membranes around chro-
matin that takes place in late anaphase is accompanied by
the accumulation of LAPs, LBR, and lamins at the chro-
mosome surfaces (for review see Gerace and Foisner,
1994; Marshall and Wilson, 1997). This process is hypothe-
sized to be driven by cooperative binding interactions be-
tween integral membrane proteins, chromatin components,
and lamins (Yang et al., 1997). Because of its properties as
an intermediate filament meshwork, the lamina could con-
tribute mechanical stability to the NE during interphase,
and could also play an important role in regulating the in-
terphase growth of the NE that occurs in cycling cells
(Gerace and Burke, 1988). A role for the lamina in nuclear
growth is consistent with studies involving the assembly of
lamin-deficient nuclei in vivo in mitotic mammalian cells
(Benavente and Krohne, 1986) and in vitro in 
 
Xenopus
laevis
 
 egg extracts (Newport et al., 1990; Meier et al., 1991;
Goldberg et al., 1995; Spann et al., 1997), where nuclear
size increase was impaired upon lamin depletion.
In this study, we have analyzed the functions of LAP2
by microinjecting recombinant fragments of this protein
into HeLa cells. We found that injection of a 398–amino
acid fragment comprising the nucleoplasmic domain of
LAP2 into metaphase cells had no detectable effect on
subsequent reassembly of the NE, but strongly inhibited
the postmitotic increase in nuclear volume. This effect was
most likely because of lamin binding, because it also was
obtained with a 76–amino acid fragment of LAP2 compris-
ing its lamin-binding region. Similarly, injection of the
lamin-binding fragment of LAP2 into early G1 phase cells
almost completely inhibited the 
 
z
 
threefold increase in nu-
clear volume that normally occurred in the subsequent 10 h,
and correspondingly inhibited entry of cells into S phase.
These data suggest a function for LAP2 in regulating dy-
namics of the nuclear lamina, and support the possibility
that the nuclear lamina is directly involved in nuclear vol-
ume increase during interphase of cycling cells. We discuss
the possible existence of a cell cycle checkpoint linking S
phase to nuclear volume.
 
Materials and Methods
 
Expression of Recombinant LAP2 Fragments
 
For production of the glutathione-S-transferase (GST) fusion protein con-
taining amino acids 298–373 of LAP2, the corresponding cDNA sequence
was excised from the rat LAP2 cDNA clone (Furukawa et al., 1995) by di-
gestion with HincII and XhoI, and then was inserted into SmaI and XhoI
sites of the vector pGEX-2T (Pharmacia Biotechnology, Inc., Piscataway,
NJ). The resulting plasmid was transformed into 
 
Escherichia coli
 
 strain
BL21. The GST fusion protein was expressed and purified according to
the manufacturer’s protocol.
To obtain an expression plasmid encoding the maltose-binding protein
(MBP) fused to residues 298–373 of LAP2, the cDNA sequence encoding
the corresponding region of LAP2 was excised by BamHI and HindIII di-
gestion from the vector pGEX-LAP2 (298–373), and then was inserted
into the vector pMALc (New England Biolabs, Inc., Beverly, MA). A
DNA linker was prepared by hybridizing two oligonucleotides (5
 
9
 
-AGCT-
TAGTCTAGACTAG-3
 
9
 
 and 5
 
9
 
-AGCTCTAGTCTAGACTA-3
 
9
 
) and
inserting this into the HindIII site of the previous pMALc-LAP2 (298–
373) construct to create a termination codon for the fusion protein. To ob-
tain an expression plasmid encoding MBP fused to residues 1–88 of LAP2,
the relevant LAP2 sequence was cleaved by BamHI and HindIII digestion
from plasmid (His)
 
6
 
-LAP2 (1–88) (provided by Dr. C. Fritze, The Scripps
Research Institute, La Jolla, CA), and then was inserted into the pMALc
vector containing the linker with the termination codon.
MBP-LAP2 (298–373) and MBP-LAP2 (1–88) were expressed in 
 
E.
coli
 
 strain BL21 and were affinity purified by binding to amylase beads ac-
cording to the manufacturer’s instructions (New England Biolabs, Inc.).
The MBP-LAP2 (1–88) prepared by this method yielded a single band on
an SDS gel after staining with Coomassie blue, and was used for injection
without further purification. However, MBP-LAP2 (298–373) required
further purification by FPLC chromatography on a Mono S column (Phar-
macia Biotechnology, Inc.) to yield a single band of the expected size. For
this, partially purified MBP-LAP2 (298–373) eluted from the amylase
beads was first dialyzed into a buffer containing 20 mM Tris, pH 8.0, and
then was loaded onto the Mono S column, which was eluted with a 0–500
mM NaCl gradient in the same buffer. Essentially pure MBP-LAP2 (298–
373) eluted at 200 mM NaCl. His-tagged protein LAP2 (1–398) (provided
by Dr. C. Fritze) was expressed in 
 
E. coli
 
 strain BL21 and purified by Ni-
NTA agarose beads (QIAGEN Inc., Chatsworth, CA) according to the
manufacturer’s instructions.
All proteins used for microinjection were concentrated to 1–2 mg/ml by
a collodion bag system using a 25-kD cutoff membrane (Schleicher &
Schuell, Inc., Keene, NH) and were dialyzed against a solution containing
10 mM Hepes-KOH, pH 7.4, 120 mM KCl for microinjection. The dia-
lyzed proteins were aliquoted and stored at 
 
2
 
20
 
8
 
C.
 
Cell Culture and Microinjection
 
HeLa and NRK cells were grown at 37
 
8
 
C in a humidified incubator con- 
Yang et al. 
 
Inhibition of Nuclear Volume Increases by LAP2 Fragment
 
1079
 
taining 5% CO
 
2
 
 in DME containing high glucose (GIBCO BRL, Gaith-
ersburg, MD), 10% FBS (Hyclone Laboratories, Logan, UT) and 100 U/
ml penicillin and streptomycin (GIBCO BRL). The day before microin-
jection, the cells were plated in 35-mm tissue culture plates (Corning
Glass Works, Corning, NY) containing glass coverslips (Fisher Scientific
Co., Pittsburgh, PA). All recombinant LAP2 fragments were microin-
jected at a concentration of 1 mg/ml in the experiments shown. However,
we obtained very similar results by injecting the LAP2 fragments at a con-
centration of 0.1 mg/ml. Protein samples were centrifuged for 15 min at
13,000 
 
g
 
 before microinjection. The microinjected cells were identified by
coinjecting the LAP2 fragments with either 0.2 mg/ml purified rabbit IgG,
or with 0.2 mg/ml rhodamine, or fluorescein-conjugated rabbit IgG (Bec-
ton and Dickinson, Co., Mountain View, CA). The rabbit IgG was de-
tected by immunofluorescent staining.
Experiments involving microinjection of LAP2 fragments into mitotic
HeLa or NRK cells used exponentially growing cultures. Metaphase cells
were selected for injection by their appearance in phase contrast micros-
copy. For experiments involving injection of synchronized interphase (G1
or S phase) HeLa cells, we first obtained synchronized mitotic popula-
tions. For this, HeLa cells growing on 150-cm
 
2
 
 plates were incubated in
medium containing 2 mM thymidine (Aldrich Chemical Co., Milwaukee,
WI) for 11 h to accumulate cells in S phase. The thymidine-containing me-
dium was replaced by normal growth medium for an additional 2 h, and
the cells were then incubated for another 11 h in medium containing 0.075
 
m
 
g/ml nocodazole (Sigma Chemical Co., St. Louis, MO) to accumulate
cells in M phase. M phase cells were then selected by mechanical shake
off, and were replated in normal growth medium in 35-mm plates contain-
ing coverslips. In experiments where DNA replication was monitored by
bromodeoxyuridine (BrdU) incorporation, cells were plated in medium
containing 10 
 
m
 
M BrdU after the shake off; or alternatively, were pulse la-
beled for 30 min in medium containing 10 
 
m
 
M BrdU before fixation in 4%
formaldehyde for immunofluorescence microscopy.
For analysis of nuclear protein import, cells that had been injected with
rhodamine-conjugated rabbit IgG were injected with FITC-conjugated
NLS-BSA (1 mg/ml), prepared as described (Paschal and Gerace, 1995)
and kindly provided by Dr. A. Dickmanns (The Scripps Research Insti-
tute). The cells were fixed for examination by fluorescence microscopy af-
ter 30 min incubation at 37
 
8
 
C.
 
Antibodies
 
Lamins A/C and B were detected with polyclonal guinea pig antibodies
(Burke and Gerace, 1986). LAP1, LAP2, and nuclear pore complex glyco-
proteins were detected with the RL13 (Senior and Gerace, 1988), RL29
(Foisner and Gerace, 1993), and RL1 (Snow et al., 1987) mAbs respec-
tively. The relevant hybridomas were grown in EXCELL 300 serum-free
medium (JRH Biosciences, Lenexa, KS); and mAbs were purified from
the culture supernatants by ammonium sulfate precipitation followed by
chromatography on a protein G column (Pharmacia Biotechnology). The
anti-LAP2 antibody (RL29) specifically recognizes LAP2 (thymopoietin
 
b
 
) but not the other two characterized proteins (thymopoietins 
 
a
 
 and 
 
g
 
)
that arise from alternative splicing of the primary LAP2 transcript (Harris
et al., 1994).
 
Immunofluorescence Microscopy
 
The localization of various NE proteins in injected cells was determined
by indirect immunofluorescence microscopy (Yang et al., 1997). HeLa
cells growing on glass coverslips were fixed in 4% formaldehyde in PBS
for 6 min at room temperature, permeabilized with 0.2% Triton X-100 in
PBS for another 6 min, and then treated with PBS containing 0.2% gela-
tin. Cells were then incubated with primary antibodies diluted in PBS/gel-
atin for 1 h at room temperature, washed in PBS, incubated for another 40
min at room temperature with secondary antibodies diluted in PBS/gela-
tin, and then finally washed in PBS. mAbs RL13 (mouse IgG), RL29
(hamster IgG), and RL1 (mouse IgM) were used at 25 
 
m
 
g/ml, and were
detected with fluorescein-conjugated, sheep anti–mouse IgG or IgM, or
fluorescein-conjugated, donkey anti–hamster IgG (Molecular Probes Inc.,
Eugene, OR). Polyclonal guinea pig antibodies were detected with fluo-
rescein-conjugated, donkey anti–guinea pig IgG (Becton and Dickinson,
Co.). BrdU incorporation was determined by immunofluorescent staining
using FITC-conjugated anti-BrdU antibodies (Becton and Dickinson,
Co.) according to the manufacturer’s instructions. The specimens were
mounted in slowfade antifade solution (Molecular Probes Inc.) and exam-
ined with an Axiophot microscope (Carl Zeiss, Inc., Thornwood, NY) or a
laser-scanning confocal microscope (MRC-600; Bio-Rad Laboratories,
Hercules, CA).
 
EM
 
To carry out EM on injected cells, cells were plated in 35-mm plates con-
taining pieces of Aclar embedding film (Ted Pella, Inc., Redding, CA).
Cells were coinjected with MBP-LAP2 (298–373), 5-nm colloidal gold par-
ticles (for identification of injected cells in EM sections), and FITC-conju-
gated, 150-kD dextran (for localization of injected cells on the film cover-
slips). After incubation at 37
 
8
 
C for appropriate times, the cells attached to
the embedding film were fixed for 30 min in 2% glutaraldehyde, 1% tan-
nic acid in PBS, and then were processed for silver enhancement as de-
scribed (Barry, 1995) using a silver enhancement kit (Ted Pella, Inc.). The
microinjected cells were identified under the fluorescence microscope by
FITC fluorescence and marked by inscribing a frame around them or re-
moving surrounding uninjected cells with a microinjection needle. The
cells were then fixed with 1% OsO
 
4
 
 for 1 h at room temperature and rele-
vant portions of the Aclar film were excised. Samples were dehydrated
and embedded in Epon 812 resin as described (Guan et al., 1995), with the
film and attached cells resting in the bottom of a plastic microtiter well.
After polymerization of the resin, the Epon block was removed from the
plastic microtiter well. The relevant marked areas in the Aclar film (con-
taining microinjected cells) were identified with a dissecting microscope,
and thin sections containing these areas were obtained. Thin sections were
stained with 2% uranyl acetate for 1 min. Micrographs were recorded with
a Hitachi 600 electron microscope (Hitachi Instruments Inc., San Jose,
CA) at 80 kV. The injected cells were identified by the coinjected gold
particles, which appeared as black spots in the cells because of the silver
enhancement. For determining the relative density of nuclear pore com-
plex (NPCs) in the NE of cells injected with LAP2 (1–88) or LAP2 (298–
373), we selected micrographs containing cross-sections of the NE, and
scored the number of NPCs per contour length of the NE (145 and 459
NPCs were scored for cells injected with LAP2 [1–88] and LAP2 [298–
373], respectively).
 
Nuclear Volume Calculation
 
To calculate the nuclear volume in synchronized cells, cultures were fixed
at appropriate times with formaldehyde and stained for immunofluores-
cence microscopy with anti–lamin B polyclonal antibodies to delineate the
NE. A Z series of fluorescent images was collected with the confocal mi-
croscope through the entirety of the nucleus from top to bottom. In most
cases, 20 sections were collected in the Z series, and each section was 0.36-
 
m
 
m thick. In each section, the pixel number in the nucleus (whose bound-
ary was marked by lamin B) was calculated using Photoshop (Adobe Sys-
tems, Mountain View, CA), and then was converted to the nuclear area
on the basis of the magnification. The fractional nuclear volume in each
section was calculated as the intranuclear area multiplied by the section
thickness. The total volume of each nucleus was obtained by summing the
fractional nuclear volumes in all sections containing a portion of the nu-
cleus. The average nuclear volume of 20 cells was determined for each ex-
periment. When this method was used to calculate the volume of fluores-
cent beads of a known size, the calculated volume closely matched the
actual value.
 
Results
 
Effect of Nucleoplasmic Segments of LAP2 on Nuclear 
Assembly and Growth at the End of Mitosis
 
To study a possible role of LAP2 in NE reassembly at the
end of mitosis, we injected metaphase HeLa cells with a
variety of monoclonal and polyclonal antibodies raised
against this protein. None of the antibodies prevented as-
sembly of LAP2 in the NE, nor did they have any detect-
able effects on NE reformation (data not shown). As an
alternative strategy for disrupting LAP2 function, we in-
vestigated whether various fragments from the nucleoplas-
mic domain of rat LAP2 would have a dominant negative
effect on NE reformation or nuclear structure when in-
jected into metaphase HeLa cells. We expected that these 
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soluble LAP2 fragments might act as competitive inhibi-
tors of the endogenous, membrane-integrated LAP2.
In initial experiments, we injected the mitotic cells with
a recombinant protein comprising nearly the entire nucleo-
plasmic domain of LAP2 (residues 1–398; Furukawa et al.,
1995) (Fig. 1, lane 
 
3
 
) or with various control proteins, and
examined the cells 2 h later. Under these conditions, the
cells that had been injected with control proteins (IgG or
GST), completed mitosis, and by phase contrast micros-
copy appeared as pairs of daughter cells with well-defined
G1 nuclei containing decondensed chromatin (Fig. 2, 
 
B
 
and 
 
F
 
; and data not shown). Interestingly, the cells that
had been injected with LAP2 (1–398) (Fig. 2, 
 
A
 
 and 
 
E
 
)
completed mitosis like the control cells, but the nuclei in
these cells had a markedly reduced size, even though they
appeared to contain decondensed chromatin and nucleo-
luslike phase dense bodies. Immunofluorescent staining
showed that despite the reduction in nuclear size, lamins
A/C and B assembled in the nuclei of the LAP2 injected cells,
similar to the control cells (Fig. 2, compare 
 
A
 
 and 
 
E
 
 to 
 
B
 
and 
 
F
 
). Lamin B appeared in a distinct nuclear rim,
whereas lamins A/C appeared both in a nuclear rim and in
intranuclear foci. These results on lamins A/C localization
are in accord with previous findings showing that a frac-
tion of lamin A appears in intranuclear foci as well as the
NE in some cultured mammalian cells in early G1 phase,
although all detectable lamin A becomes localized at the
NE later in G1 phase (Bridger et al., 1993; Gerace, L., un-
published results).
We also carried out immunofluorescent staining of in-
jected cells to localize LAP1, LAP2, and a group of NPC
glycoproteins recognized by the RL1 mAb. We found that
these proteins were all assembled in the NE of cells in-
jected with LAP2 (1–398) in a manner indistinguishable
from the control cells (data not shown; see below). Thus, a
protein fragment comprising the nucleoplasmic domain of
LAP2 appears to inhibit nuclear volume increase after nu-
clear reformation, but does not have a detectable effect on
assembly of a variety of NPC and lamina markers in the
NE (including LAP2).
The inability of the nucleoplasmic domain of LAP2 to
inhibit the targeting of endogenous LAP2 to the NE at the
Figure 1. Analysis of LAP2
fragments used for microinjection
by SDS-PAGE. Samples of re-
combinant proteins used for mi-
croinjection were electropho-
resed on a 10% SDS gel, that
was stained with Coomassie blue.
MW, molecular weight standards;
lane  1, MBP-LAP2 (298–373);
lane  2, MPB-LAP2 (1–88); lane 3,
His-tagged LAP2 (1–398).
Figure 2. Effect of microinjected LAP2 fragments on nuclear ref-
ormation and lamin assembly at the end of mitosis. Metaphase
HeLa cells were injected with a variety of proteins and incubated
for 2 h at 378C before fixation and immunofluorescent staining.
All injectates contained rabbit IgG to mark the injected cells. In
addition, the injectates contained: A and E, LAP2 (1–398); B and
F, rabbit IgG only; C and G, MBP-LAP2 (298–373); D and H,
MBP-LAP2 (1–88). Shown are phase contrast images (left col-
umn), or epifluorescence images staining with anti–rabbit IgG
(middle column), and with antilamins (right column; A–D, anti-
lamins A/C; E–H, antilamin B). Bar, 20 mm. 
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end of mitosis has a number of possible explanations. For
example, it is possible that the LAP2 fragment, which lacks
the transmembrane and lumenal domains of intact LAP2,
does not interact with all the NE-binding sites of the en-
dogenous LAP2, or that the affinity of the LAP2 fragment
for the NE-binding sites is significantly lower than the af-
finity of the intact LAP2 (e.g., because of the quaternary
structure of the latter). However, this is not because of the
injection of a heterologous (rat) LAP2 fragment into hu-
man (HeLa) cells, since the same phenotype (inhibition of
nuclear growth but not the assembly of LAP2 into the NE)
was obtained by injecting rat LAP2 (1–398) into NRK
(rat) cells (data not shown). The lack of an effect of LAP2
(1–398) (or the minimal lamin binding region of LAP2, see
below) on reassembly of lamins in our system does not
rule out the possibility that these proteins could affect
lamin assembly with other experimental conditions, since
the intranuclear concentration of the LAP2 fragments might
be limiting during the short period after nuclear membrane
reformation when the assembly of most nuclear lamins
takes place in cultured mammalian cells (Yang et al., 1997).
We have recently delineated the lamin- and chromatin-
binding regions in LAP2 (Furukawa K., C. Fritze, and L.
Gerace, manuscript submitted for publication). Using a
yeast two-hybrid approach, we have found that a mini-
mal lamin B–binding region occurs between residues 298–
373 of LAP2. Moreover, using an immunofluorescent chro-
mosome binding assay with recombinant segments of
LAP2, we determined that the chromatin-binding region
of LAP2 lies between residues 1–88. We took advantage
of this information to investigate whether the ability of the
nucleoplasmic domain of LAP2 to inhibit the increase in
nuclear volume could be assigned to a region that we have
implicated in either lamin or chromatin binding.
For this purpose we prepared recombinant proteins con-
taining the MBP fused to either the chromatin-binding re-
gion or the lamin B–binding region of LAP2 (Fig. 1, lanes
 
1
 
 and 
 
2
 
). Microinjection analysis similar to that described
above showed that cells injected with MBP-LAP2 (1–88)
underwent normal mitosis and assembly of lamins, and
were indistinguishable in their nuclear size from the con-
trol cells injected only with IgG (Figs. 2, 
 
D
 
 and 
 
H
 
, and 3,
 
A–C
 
). By contrast, cells injected with MBP-LAP2 (298–
373) showed strong inhibition of nuclear growth similar to
that seen with LAP2 (1–398), even though assembly of
lamins was normal (Figs. 2, 
 
C
 
 and 
 
G
 
, and 3, 
 
D–F
 
). In initial
studies we obtained very similar results with GST fusion
proteins containing each of the three LAP2 fragments
(data not shown). However, since GST is a dimer and the
dimeric GST fusion proteins could potentially cross-link
lamins, we believed it important to perform the experi-
ments with MBP fusions, which are monomers.
We then used confocal fluorescence microscopy to com-
pare the assembly of LAP1, LAP2, and the RL1 NPC anti-
gens in the cells injected with MBP-LAP2 (298–373) and
MPB-LAP2 (1–88) (Fig. 3). LAP1 and LAP2, as well as the
RL1 antigens, were localized at the nuclear periphery of
cells injected with MBP-LAP2 (298–373), similar to cells
injected with MBP-LAP2 (1–88). Thus, although nuclear
volume increase is inhibited when mitotic HeLa cells are
injected with MBP-LAP2 (298–373), a variety of nuclear
lamina and NPC proteins still become assembled in the NE.
In further studies, we used thin section EM to examine
the ultrastructure of nuclei in the cells that had been in-
jected with LAP2 (298–373) or LAP2 (1–88) as above. The
nuclei of cells injected with LAP2 (298–373) usually had a
convoluted surface and a shape similar to that of late telo-
phase nuclei (Fig. 4 
 
B
 
), consistent with their appearance in
confocal light microscopy (Fig. 3). This contrasted with the
more spherical shape of nuclei in cells injected with LAP2
(1–88) (Figs. 3 and 5 
 
B
 
). In cells injected with LAP2 (298–
373), the chromatin was extensively decondensed, and
lined the inner surface of the NE in an almost continuous
fashion, except for interruptions at the pore complexes
(Fig. 4 
 
C
 
). This was similar to cells injected with LAP2 (1–
88) (Fig. 5 
 
C
 
). Finally, the NE of cells injected with LAP2
(298–373) had a normal double membrane and character-
istic NPCs, like the cells injected with LAP2 (1–88). One
difference between the two types of injected cells, however,
was the density of NPCs in the NE, which was 1.7-fold
greater in cells injected with LAP2 (298–373), compared
to cells injected with LAP2 (1–88), as determined by quan-
titative analysis (see Materials and Methods). The differ-
ence in density of pore complexes is apparent in tangential
sections of the nuclear surface of these two classes of in-
jected cells (compare Figs. 4 
 
A
 
 and 5 
 
A
 
). This difference is
probably because of continued assembly of NPCs in NEs
Figure 3. Effect of microinjected LAP2 fragments on reassembly
of LAPs and pore complex proteins at the end of mitosis.
Metaphase HeLa cells were injected with rabbit IgG plus MBP-
LAP2 (1–88) (A–C) or MPB-LAP2 (298–373) (D–F). After incu-
bation for 2 h at 378C, cells were fixed and stained for immunoflu-
orescence microscopy. Shown are confocal fluorescence images
of staining with anti–rabbit IgG (left image in A–F) and with anti-
bodies against various NE proteins (right image in A–F): A and
D, anti-LAP1; B and E, anti-LAP2; C and F, RL1. Bar, 20 mm. 
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in which the increase in surface area was inhibited by in-
jection of LAP2 (298–373).
We also examined the nuclear transport capacity of cells
that had been injected with the LAP2 fragments. For this
we coinjected a fluorescent reporter protein containing
basic amino acid–type nuclear localization signals (FITC-
labeled NLS-BSA; see Materials and Methods) into the
metaphase cells and examined the localization of the fluo-
rescent import substrate after 2 h. We found that after 30
min the transport substrate was highly concentrated in the
nuclei of cells injected with LAP2 (298–373), like cells in-
jected with LAP2 (1–88) (data not shown). Thus, the nu-
clei of the injected cells appear to be intact and are capa-
ble of actively importing nuclear proteins. Similar results
were obtained when interphase cells were injected with
these LAP2 fragments (see Fig. 8; below). In conclusion,
cells injected with the lamin-binding fragment of LAP2
(298–373) assemble a NE with apparently normal struc-
tural and functional features. Aside from an increase in
NPC density in the NE, the only clear difference in these
injected cells was a marked inhibition of nuclear growth.
 
Inhibition of Interphase Nuclear Volume Increase by 
the Lamin-binding Fragment of LAP2
 
We next examined whether the lamin-binding domain of
LAP2 could inhibit the substantial increase in nuclear vol-
ume that occurs during interphase in cycling cells (Maul et al.,
1972; Fidorra et al., 1981). For this experiment, the LAP2
fragment was injected into early G1 phase cells, which have
a fully assembled and functional NE. Mitotic HeLa cells
were selected by mechanical shake off from nocodazole-
Figure 4. Electron microscopy of G1 phase cells injected with
LAP2 (298–373) at metaphase. Shown are thin section electron
micrographs depicting the nucleus of cells that were injected with
LAP2 (298–373) at metaphase and returned to culture for 2 h.
Nuclear (N) and cytoplasmic (C) areas are indicated. A shows a
tangential section of the nuclear surface, whereas B and C show
cross-sections of the nucleus. Nuclear pore complexes are indi-
cated by arrows. Bars, 1 mm.
Figure 5. EM of G1 phase cells injected with LAP2 (1–88) at
metaphase. Shown are thin section electron micrographs depict-
ing the nucleus of cells injected with LAP2 (1–88) at metaphase
and returned to culture for 2 h. Nuclear (N) and cytoplasmic (C)
areas are indicated. A shows a tangential section of the nuclear
surface, whereas B and C show cross-sections of the nucleus.
Bars, 1 mm.Yang et al. Inhibition of Nuclear Volume Increases by LAP2 Fragment 1083
arrested cultures and were returned to culture in the ab-
sence of nocodazole for 2 h to allow progression into G1.
The cells then were injected with MBP-LAP2 (298–373) or
the control fragment, MBP-LAP2 (1–88), and nuclear vol-
ume was examined 10 h later. Immunofluorescent staining
demonstrated that both proteins entered the nucleus quite
rapidly; at 2 h after microinjection, MBP-LAP2 (1–88) was
present in both the nucleus and the cytoplasm at similar
levels, whereas MBP-LAP2 (298–373) was somewhat more
concentrated in the nucleus than in the cytoplasm at this
time (data not shown). The mechanism by which the fu-
sion proteins enter the nucleus (i.e., passive diffusion or
active transport) is unknown.
Phase contrast microscopy demonstrated that at 10 h af-
ter microinjection, the nuclei of cells injected with MBP-
LAP2 (298–373) were very small compared to the nuclei
of uninjected cells (e.g., Fig. 6 A), whereas the nuclei of
cells injected with MBP-LAP2 (1–88) were roughly the same
size as the nuclei of control cells (e.g., Fig. 6 C). We quan-
titatively analyzed the changes in nuclear volume that took
place in cells microinjected with MBP-LAP2 (298–373) or
in injected controls during this 10-h period (Table I). We
determined that the nuclei of uninjected HeLa cells on av-
erage underwent an zthreefold increase in nuclear vol-
ume between 2 and 12 h after mitosis. In sharp contrast,
the nuclei of cells injected with MBP-LAP2 (298–373) at 2 h
after mitosis had virtually the same volume 10 h later.
However, if cells were injected with MBP-LAP2 (298–373)
at 10 h after mitosis, 2 h later they had the same volume as
uninjected cells at 12 h after mitosis. Therefore, MBP-LAP2
(298–373) acts to prevent an increase in nuclear volume
during interphase, but cannot induce a decrease in the vol-
ume of nuclei that have already grown by progression
through the cell cycle.
Inhibition of Progression into S Phase by the Lamin-
binding Fragment of LAP2
We next investigated whether the lamin-binding fragment
of LAP2 had an effect on progression of cells into S phase,
in addition to its inhibition of nuclear volume increase
during interphase. Under our synchronization conditions,
the percentage of cells in S phase was greatest at 10–12 h
after release from the nocodazole block (Fig. 7 A). Early
G1 phase HeLa cells (2 h after nocodazole release) were
injected with MBP-LAP2 (298–373) or MBP-LAP2 (1–88),
and were incubated for another 10 h. Cells were then pulse
labeled with BrdU (a thymidine analogue) and examined
by immunofluorescent staining to detect the incorporation
of BrdU into nuclear DNA (Figs. 6, A and C). A majority
of cells injected with MBP-LAP2 (1–88) incorporated BrdU
in their nucleus (Fig. 6 C), whereas almost no nuclei of
cells injected with LAP2 (298–373) showed BrdU incorpo-
ration (Fig. 6 A). Quantitative analysis demonstrated that
only 8% of the cells injected with LAP2 (298–373) incor-
porated BrdU, in contrast to 53% of the cells injected with
LAP2 (1–88) and 55% of the uninjected cells (Fig. 7 B). A
similar result was obtained when MBP-LAP2 (298–373)–
injected cells were cultured continuously in BrdU-contain-
ing medium for the 10 h after microinjection, instead of
being pulse labeled with BrdU at the end of this period
(data not shown).
To examine whether the MBP-LAP2 (298–373) had an
inhibitory effect on ongoing DNA replication, cultures
were incubated for 10 h after the nocodazole release, to
the time when a maximum percentage of cells were in S
phase, and then were injected with MBP-LAP2 (298–373)
or MBP-LAP2 (1–88). 2 h later, the cells were pulse la-
beled with BrdU and examined by immunofluorescent
staining (Figs. 6, B and D). Under these conditions, a ma-
Figure 6. Effect of injected LAP2 fragments cells on interphase
nuclear growth and progression to S phase. Mitotic HeLa cells
were obtained by shake off, and returned to culture. Some cells
were injected with MBP-LAP2 (298–373) either 2 h (A and E) or
10 h (B) later. Other cells were injected with MBP-LAP2 (1–88)
either 2 h (C) or 10 h (D) later. All injectates also contained rab-
bit IgG. 12 h after the mitotic cells were returned to culture, the
cultures in A–D were pulse labeled with BrdU for 30 min, and
were fixed and processed for immunofluorescence microscopy as
indicated. The culture in E was fixed at 12 h. Shown are phase
contrast images (A–D, left column), or epifluorescence images of
staining with anti-BrdU (A–D, middle column), and with anti–
rabbit IgG (A–D, right column). E shows confocal fluorescence
images of staining with antilamins A/C (left) and with anti-IgG
(right). Bars, 10 mm.The Journal of Cell Biology, Volume 139, 1997 1084
jority of the cells injected with LAP2 (298–373) incorpo-
rated BrdU (Fig. 6 B), similar to cells injected with LAP2
(1–88) (Fig. 6 D). Quantitative analysis showed that 53%
of the cells injected with LAP2 (298–373) were labeled with
BrdU, which does not differ significantly from the unin-
jected control (Fig. 7 B). This demonstrates that the lamin-
binding fragment of LAP2 does not inhibit ongoing DNA
replication once cells have reached S phase. Rather, inhi-
bition of DNA replication occurs only when the fragment
is injected into early G1 phase cells and a clamp is imposed
on nuclear volume.
We performed a series of additional experiments to in-
vestigate the basis for the inhibition of DNA replication in
these injected cells. First, we carried out immunofluorescent
staining to examine the localization of nuclear lamins at 12 h
after mitosis in the cells that had been injected with LAP2
(298–373) 2 h after the nocodazole release. This experi-
ment showed that lamins A/C remain highly concentrated
at the NE in these cells (Fig. 6 E), similar to uninjected
cells. Thus LAP2 (298–373) does not mediate inhibition of
DNA replication by inducing lamin disassembly. Further-
more, the lack of cytoplasmic or intranuclear aggregates of
lamins suggest that newly synthesized lamins are normally
assembled in the NE. Next, we investigated whether there
was an obvious deficiency in nuclear protein import in the
injected cells. In one experiment, exponentially growing
cells were injected with LAP2 (298–373) or LAP2 (1–88),
and 2 h later were injected with a nuclear import substrate
(FITC-NLS-BSA) (Figs. 8, A and B). In a second experi-
ment, early G1 phase cells were injected with LAP2 (298–
373) or LAP2 (1–88), and 10 h later were injected with
FITC-NLS-BSA (Figs. 8, C and D). In both of these exper-
iments, after 30 min the substrate became highly concen-
trated in the nucleus of the cells injected with LAP2 (298–
373) (Figs. 8, A and C), similar to the cells injected with
LAP2 (1–88) (Figs. 8, B and D). All of the injected cells
showed rapid import kinetics, since most of the transport
substrate had accumulated in the nucleus within 5–10 min
of injection (data not shown). This demonstrates that in-
jection of LAP2 (298–373) into interphase cells did not de-
tectably disrupt either the structure of the NE or its capac-
ity for nuclear import.
Discussion
Functions of LAP2 Related to Nuclear
Lamina Dynamics
We have found that microinjection of a soluble recombi-
nant protein comprising the nucleoplasmic domain of
LAP2 into metaphase HeLa cells strongly inhibits the in-
crease in nuclear volume that occurs in early G1 phase,
even though the cells assemble an apparently normal,
transport-competent NE, containing LAP1, LAP2, lamins,
and NPCs. This phenotype appears to be due to lamin
binding by the LAP2 fragment, because an identical effect
is achieved with the 76–amino acid segment of the nucleo-
Table I. Effect of LAP2 (298–373) on Nuclear Volume Increase 
during the Cell Cycle
Treatment None None
Injection with
LAP2 (298–373)
at 2 h
Injection with
LAP2 (298–373)
at 10 h
Sampling time* 2 h 12 h 12 h 12 h
Nuclear volume‡ 312 6 183 895 6 254 350 6 178 882 6 215
(mm3)
*Time after release from nocodazole block.
‡Average of 20 cells, determined as in Materials and Methods.
Figure 7. Quantitative analysis of effect of injected LAP2 (298–
373) on progression of cells into S phase. (A) Kinetics of S phase
progression. After selection of mitotic HeLa cells by shake off,
the cells were returned to culture in medium containing BrdU
and were fixed at various times and processed for immunofluo-
rescence microscopy with anti-BrdU. The percentage of cells
showing BrdU staining is indicated. (B) Mitotic cells obtained by
shake off were returned to culture, and cells were injected with
LAP2 (298-373) at 2 h (black bar), or at 10 h (white bar), or with
LAP2 (1–88) at 2 h (lightly shaded bar). The cultures injected
with LAP2 (298–373) and LAP2 (1–88) at 2 h, and a control unin-
jected culture (darkly shaded bar), were grown in medium con-
taining BrdU from 2–12 h, and the cells were then fixed and pro-
cessed for immunofluorescence microscopy with anti-BrdU. The
culture injected with LAP2 (298–373) at 10 h was pulse labeled
with BrdU for 30 min at 12 hr, and the cells were then fixed and
stained with anti-BrdU. Shown are the percent of each popula-
tion that incorporated BrdU.Yang et al. Inhibition of Nuclear Volume Increases by LAP2 Fragment 1085
plasmic domain of LAP2 (LAP2 [298–373]) that repre-
sents its minimal lamin-binding region. By contrast, no ef-
fect is seen with the LAP2 fragment that contains its
chromatin-binding domain (LAP2 [1–88]).
The injection of LAP2 (298–373) into early G1 phase
cells produces an effect similar to that seen in mitotic cells.
The LAP2 fragment completely inhibits the zthreefold in-
crease in nuclear volume that normally occurs during the
ensuing 10 h of the cell cycle, without detectably perturb-
ing NE structure or nuclear import. In this case, inhibition
of nuclear growth by the LAP2 fragment is clearly unre-
lated to mitotic NE reassembly, because the G1 cells have
a functional interphase NE at the time of injection.
We believe that the clamp on nuclear volume imposed
by the lamin-binding fragment of LAP2 most likely is be-
cause of its interference with the normal structural dynam-
ics of the nuclear lamina, which in turn could inhibit an in-
crease in NE surface area and nuclear volume (see below).
In principle, growth of the lamina may be driven by reor-
ganization of assembled lamins and/or by insertion of new
lamin subunits (Gerace et al., 1984; Gerace and Burke, 1988).
The injected LAP2 fragments do not appear to interfere
with incorporation of lamins in the NE at the end of mito-
sis or during interphase, but could nevertheless modify the
pathway of lamin insertion, and indirectly influence the ex-
pansion of the assembled lamina. Alternatively, they could
directly block expansion of the nuclear lamina by binding
to a site on nuclear lamins required for lamina growth.
However, we can clearly exclude the possibility that the
microinjected LAP2 fragments are freezing the structure
of the lamina by cross-linking lamins, since the MBP fu-
sions we used for these studies are monomers.
The microinjected LAP2 fragments probably do not
bind to the lamina in a fashion identical to the endogenous
LAP2. This is because the endogenous LAP2 is a mem-
brane-integrated protein, and unlike the soluble LAP2 frag-
ments, should have topological access only to the surface
of the lamina filaments facing the inner nuclear membrane.
Nevertheless, we consider it likely that the injected LAP2
fragments are mimicking a normal function of LAP2. Thus,
our data suggest that one function of LAP2 is to stabilize
nuclear lamina structure and/or negatively regulate lamina
growth during interphase. For interphase lamina expan-
sion to occur, it may be necessary to transiently weaken or
abolish the lamin–LAP2 binding in localized regions of the
lamina. This could be achieved by a reversible, postsyn-
thetic modification(s) of LAP2. Such an effect could be
achieved by phosphorylation, since phosphorylation of
LAP2 is known to inhibit the lamin–LAP2 interaction dur-
ing mitosis (Foisner and Gerace, 1993).
Role of the Lamina in NE Growth during Interphase
A number of previous investigations have provided evi-
dence to support the notion that nuclear volume increase
involves the nuclear lamina. Injection of polyclonal anti-
lamin antibodies into mitotic cultured cells was found to
prevent most lamin assembly and to arrest nuclei in an
early telophase configuration, in which the chromosomes
were surrounded by a double membrane but remained in a
highly condensed state (Benavente and Krohne, 1986).
Further support for an involvement of the lamina in nu-
clear growth came from studies involving in vitro nuclear
assembly with Xenopus egg extracts. It was found that im-
munological depletion of the major egg lamin LIII (New-
port et al., 1990; Goldberg et al., 1995), or inhibition of LIII
assembly by the addition of anti-LIII antibodies (Meier et al.,
1991) or a dominant-negative lamin mutant (Spann et al.,
1997) resulted in the assembly of import-competent nuclei
with intact NEs, but significantly impaired nuclear growth.
However, it was unclear whether a residual nuclear lamina
involving the minor egg lamin isotypes (Lourim and Krohne,
1993; Lourim et al., 1996) was assembled in the NE under
these conditions. Our studies complement and extend these
earlier studies on the inhibition of lamin assembly. In our
experiments involving injection of the lamin-binding frag-
ment of LAP2 into G1 cells, the fragment functioned in
the context of a structurally normal NE, and most likely
acted through inhibition of lamin dynamics rather than on
assembly. Thus, the results in the present study strongly
support the notion that the increase in nuclear volume that
occurs in growing cells during interphase involves the nu-
clear lamina, at least in part. The growth of the nuclear
Figure 8. Analysis of nuclear protein import in interphase cells
injected with LAP2 fragments. (A and B) Interphase HeLa cells
in exponentially growing populations were injected with either
MPB-LAP2 (298–373) (A) or MBP-LAP2 (1–88) (B) together
with fluorescent rabbit IgG. After 2 h, the injected cells were
given a second injection with FITC-NLS-BSA. The cells were
fixed 30 min later and examined. (C and D) Mitotic HeLa cells
were selected by mitotic shake off and were returned to culture.
After 2 h, they were injected with either MPB-LAP2 (298–373)
(C) or MBP-LAP2 (1–88) (D). 10 h later, the injected cells were
given a second injection with FITC-NLS-BSA. The cells were
fixed 30 min later and examined. Shown are phase contrast im-
ages (left column), epifluorescence images of FITC-NLS-BSA
(middle column), and epifluorescence images of rhodamine-IgG
(right column). Bars, 20 mm.The Journal of Cell Biology, Volume 139, 1997 1086
lamina could be regulated both by intrinsic mechanisms
(involving insertion and rearrangement of lamins, and
modulation by lamina-associated polypeptides like LAP2
[discussed above]), and by extrinsic mechanisms (such as
changes in the volume or higher order conformation of
chromatin) (i.e., Nicolini et al., 1984).
A Nuclear Volume Checkpoint for
S Phase Progression?
In previous studies with Xenopus egg extracts where as-
sembly of lamin LIII in the NE was perturbed by various
means, an inhibition of DNA replication was observed
(Newport et al., 1990; Meier et al., 1991; Goldberg et al.,
1995; Spann et al., 1997) in addition to a deficiency in nu-
clear growth (see above). However, in some of these stud-
ies, essential DNA replication factors became concentrated
in intranuclear aggregates containing lamins (Meier et al.,
1991; Spann et al., 1997). This suggests that inhibition of
DNA replication in these cases involved removal of repli-
cation proteins from their normal site of function, at least
in part. Nevertheless, entry into S phase may be depen-
dent on assembly of the nuclear lamina and certain lamina
functions, such as chromatin anchoring to the NE (Hutchi-
son et al., 1994; Zhang et al., 1996).
Our studies showed that injection of the lamin-binding
fragment of LAP2 into HeLa cells in early G1 phase
strongly inhibited progression of cells into S phase, in ad-
dition to preventing a nuclear volume increase. However,
in contrast to the work with Xenopus egg extracts dis-
cussed above, the nuclear lamina was not disrupted in our
studies involving the microinjected LAP2 fragment. Since
LAP2 (298–373) does not bind to chromatin in vitro, or
detectably perturb ongoing DNA synthesis, NE integrity,
or nuclear import when injected into cells, these experi-
ments suggest that the microinjected LAP2 fragment in-
hibits progression of cells into S phase by imposing a clamp
on nuclear volume rather than by interfering with gross
features of nuclear or lamina organization. Nevertheless,
we cannot rule out that LAP2 (298–373) has some addi-
tional activity other than inhibition of nuclear/lamina
growth that is responsible for the inhibition of S phase
progression, or that it indirectly affects entry into S phase
by displacing some presently uncharacterized proteins from
the lamina.
A plausible model suggested by our results is that pro-
gression into S phase is dependent on the acquisition of a
certain nuclear volume. Consistent with this possibility, a
significant increase in nuclear volume occurs in a variety
of mammalian cells during G1 phase before entry into S
phase (Maul et al., 1972; Yen and Pardee, 1979; Fidorra et al.,
1981; this study). This volume requirement for S phase
progression could be mediated by two different (and not
mutually exclusive) regulatory mechanisms. In one sce-
nario, certain structural features of the nucleus that are di-
rectly linked to volume (such as the surface area of the
NE/lamina) could be necessary for the generation of an
appropriate chromatin substrate for DNA replication. Al-
ternatively, in keeping with the predominant mechanisms
that have been described for regulation of cell cycle transi-
tions (Elledge, 1996), our results raise the interesting pos-
sibility that eukaryotic cells have a cell cycle checkpoint for
entry into S phase that is related to nuclear volume. This
would be conceptually similar to the G1 commitment point
in yeast called Start that is linked to cell size (Johnston et al.,
1977, 1979; Nash et al., 1988). In the future, it will be feasi-
ble to use cultured cell lines where the lamin-binding frag-
ment of LAP2 can be inducibly expressed to investigate in
detail the possible existence of a nuclear volume check-
point.
 We are grateful to Dr. K. Sullivan for his help in developing the method
for determining nuclear volume. We also thank Drs. S. Lyman and C.
Fritze for their helpful comments on the manuscript.
This work was supported by grant No. GM28521 from the National In-
stitutes of Health (to L. Gerace).
Received for publication 14 August 1997 and in revised form 24 Septem-
ber 1997.
References
Barry, R.W. 1995. Pre-embedding immunocytochemistry with silver-enhanced
small gold particles. In Immunogold Silver Staining. M.A. Hayat, editor.
CRC Press, New York. 14:217–230.
Benavente, R., and G. Krohne. 1986. Involvement of nuclear lamins in postmi-
totic reorganization of chromatin as demonstrated by microinjection of
lamin antibodies. J. Cell Biol. 5:1847–1854.
Berger, R., L. Theodor, J. Shoham, E. Gokkel, F. Brok-Simoni, K.B. Avraham,
N.G. Copeland, N.A. Jenkins, G. Rechavi, and A.J. Simon. 1996. The char-
acterization and localization of the mouse thymopoietin/lamina-associated
polypeptide 2 gene and its alternatively spliced products. Genome Res. 5:
361–370.
Bridger, J.M., I.R. Kill, M. O’Farrell, and C.J. Hutchison. 1993. Internal lamin
structures within G1 nuclei of human dermal fibroblasts. J. Cell Sci. 104:297–306.
Burke, B. 1990. On the cell-free association of lamins A and C with metaphase
chromosomes. Exp. Cell Res. 186:169–176.
Burke, B., and L. Gerace. 1986. A cell-free system to study reassembly of the
nuclear envelope at the end of mitosis. Cell. 44:639–652.
Courvalin, J.C., N. Segil, G. Blobel, and H.J. Worman. 1992. The lamin B re-
ceptor of the inner nuclear membrane undergoes mitosis-specific phospho-
rylation and is a substrate for p34cdc2-type protein kinase. J. Biol. Chem.
267:19035–19038.
Elledge, S.J. 1996. Cell cycle checkpoints: Preventing an identity crisis. Science.
274:1664–1671.
Fidorra, J., Th. Mielke, J. Booz, and L.E. Feinendegen. 1981. Cellular and nu-
clear volume of human cells during the cell cycle. Radiat. Environ. Biophys.
19:205–214.
Foisner, R., and L. Gerace. 1993. Integral membrane proteins of the nuclear en-
velope interact with lamins and chromosomes, and binding is modulated by
mitotic phosphorylation. Cell. 73:1267–1279.
Furukawa, K., N. Panté, U. Aebi, and L. Gerace. 1995. Cloning of a cDNA for
lamina-associated polypeptide 2 (LAP2) and identification of regions that
specify targeting to the nuclear envelope. EMBO (Eur. Mol. Biol. Organ.) J.
14:1626–1636.
Georgatos, S.D., J. Meier, and G. Simos. 1994. Lamins and lamin-associated
proteins. Curr. Opin. Cell Biol. 6:347–353.
Gerace, L., and B. Burke. 1988. Functional organization of the nuclear enve-
lope. Annu. Rev. Cell Biol. 4:335–374.
Gerace, L., and R. Foisner. 1994. Integral membrane proteins and dynamic or-
ganization of the nuclear envelope. Trends Cell Biol. 4:127–131.
Gerace, L., C. Comeau, and M. Benson. 1984. Organization and modulation of
nuclear lamina structure. J. Cell Sci. Suppl. 1:137–160.
Glass, J.R., and L. Gerace. 1990. Lamins A and C bind and assemble at the sur-
face of mitotic chromosomes. J. Cell Biol. 111:1047–1057.
Goldberg, M., H. Jenkins, T. Allen, W.G.G. Whitfield, and C.J. Hutchison.
1995. Xenopus lamin B3 has a direct role in the assembly of a replication
competent nucleus: evidence from cell-free egg extracts. J. Cell Sci. 108:
3451–3461.
Guan, T., S. Müller, G. Klier, N. Panté, J.M. Blevitt, M. Haner, B. Paschal, U.
Aebi, and L. Gerace. 1995. Structural analysis of the p62 complex, an assem-
bly of O-linked glycoproteins that localizes near the central gated channel of
the nuclear pore complex. Mol. Biol. Cell 6:1591–1603.
Harris, C.A., P.J. Andryuk, S. Cline, H.K. Chan, A. Natarajan, J.J. Siekierka,
and G. Goldstein. 1994. Three distinct human thymopoietins are derived
from alternatively spliced mRNAs. Proc. Natl. Acad. Sci. USA. 91:6283–
6287.
Harris, C.A., P.J. Andryuk, S.W. Cline, S. Mathew, J.J. Siekierka, and G. Gold-
stein. 1995. Structure and mapping of the human thymopoietin (TMPO)
gene and relationship of human TMPO b to rat lamin-associated polypep-
tide 2. Genomics. 28:198–205.
Hoger, T., G. Krohne, and J. Kleinschmidt. 1991. Interaction of Xenopus laminsYang et al. Inhibition of Nuclear Volume Increases by LAP2 Fragment 1087
A and LII with chromatin in vitro mediated by a sequence element in the
carboxyterminal domain. Exp. Cell Res. 197:280–289.
Hutchison, C.J., J.M. Bridger, L.S. Cox, and I.R. Kill. 1994. Weaving a pattern
from disparate threads: lamin function in nuclear assembly and DNA repli-
cation. J. Cell Sci. 107:3259–3269.
Johnston, G.C., J.R. Pringle, and L.H. Hartwell. 1977. Coordination of growth
with cell division in the yeast Saccharomyces cerevisiae. Exp. Cell Res. 105:
79–98.
Johnston, G.C., C.W. Ehrhardt, A. Lorincz, and B.L.A. Carter. 1979. Regula-
tion of cell size in the yeast Saccharomyces cerevisiae. J. Bacteriol. 137:1–5.
Lourim, D., and G. Krohne. 1993. Membrane-associated lamins in Xenopus egg
extracts: Identification of two vesicle populations. J. Cell Biol. 123:501–512.
Lourim, D., A. Kempf, and G. Krohne. 1996. Characterization and quantitation
of three B-type lamins in Xenopus oocytes and eggs: increase of lamin L1
protein synthesis during meiotic maturation. J. Cell Sci. 109:1775–1785.
Marshall, I.C.B., and K.L. Wilson. 1997. Nuclear envelope assembly after mito-
sis. Trends Cell Biol. 7:69–74.
Martin, L., C. Crimaudo, and L. Gerace. 1995. cDNA cloning and characteriza-
tion of lamina-associate polypeptide 1C (LAP1C), an integral protein of the
inner nuclear membrane. J. Biol. Chem. 270:8822–8828.
Maul, G.G., H.M. Maul, J.E. Scogna, M.W. Lieberman, G.S. Stein, B. Y.-L.
Hsu, and T.W. Borun. 1972. Time sequence of nuclear pore formation in
phytohemagglutinin-stimulated lymphocytes and in HeLa cells during the
cell cycle. J. Cell Biol. 55:433–447.
Meier, J., K.H.S. Campbell, C.C. Ford, R. Stick, and C.J. Hutchison. 1991. The
role of lamin LIII in nuclear assembly and DNA replication, in cell-free ex-
tracts of Xenopus eggs. J. Cell Sci. 98:271–279.
Nash, R., G. Tokiwa, S. Anand, K. Erickson, and A.B. Futcher. 1988. The
WHI11 gene of Saccharomyces cerevisiae tethers cell division to cell size and
is a cyclin homolog. EMBO (Eur. Mol. Biol. Organ.) J. 7:4335–4346.
Newport, J.W., K.L. Wilson, and W.G. Dunphy. 1990. A lamin-independent
pathway for nuclear envelope assembly. J. Cell Biol. 111:2247–2259.
Nicolini, C., P. Carlo, R. Finollow, F. Vigo, B. Cavazza, A. Ledda, E. Ricci, and
G. Brambilla. 1984. Phase transition in nuclei and chromatin. Is nuclear vol-
ume controlled by the chromatin or by the nuclear matrix? Cell Biophys. 6:
183–196.
Nigg, E. 1992. Assembly-disassembly of the nuclear lamina. Curr. Opin. Cell
Biol. 4:105–109.
Nikolakakai, E., J. Meier, G. Simos, S.D. Georgatos, and T. Giannakouros.
1997. Mitotic phosphorylation of the lamin B receptor by a serine/arginine
kinase and p34 (cdc2). J. Biol. Chem. 272:6208–6213.
Paschal, B.M., and L. Gerace. 1995. Identification of NTF2, a cytosolic factor
for nuclear import which interacts with nuclear pore complex protein p62. J.
Cell Biol. 129:925–937.
Pyrpasopoulou, A., J. Meier, C. Maison, G. Simos, and S.D. Georgatos. 1996.
The lamin B receptor (LBR) provides essential chromatin docking sites at
the nuclear envelope. EMBO (Eur. Mol. Biol. Organ.) J.15:7108–7119.
Senior, A., and L. Gerace. 1988. Integral membrane proteins specific to the in-
ner nuclear membrane and associated with the nuclear lamina. J. Cell Biol.
107:2029–2036.
Snow, C., A. Senior, and L. Gerace. 1987. Monoclonal antibodies identify a
group of nuclear pore complex glycoproteins. J. Cell Biol. 104:1143–1156.
Spann, T.P., R.D. Moir, A.E. Goldman, R. Stick, and R.D. Goldman. 1997. Dis-
ruption of nuclear lamin organization alters the distribution of replication
factors and inhibits DNA synthesis. J. Cell Biol. 136:1201–1212.
Taniura, H., C. Glass, and L. Gerace. 1995. A chromatin binding site in the tail
domain of nuclear lamins that interacts with core histones. J. Cell Biol. 131:
33–44.
Worman, H.J., J. Yuan, G. Blobel, and S.D. Georgatos. 1988. A lamin B recep-
tor in the nuclear envelope. Proc. Natl. Acad. Sci. USA. 85:8531–8534.
Worman, H.J., C.D. Evans, and G. Blobel. 1990. The lamin B receptor of the
nuclear envelope inner membrane: A polytopic protein with eight potential
transmembrane domains. J. Cell Biol. 111:1535–1542.
Yang, L., T. Guan, and L. Gerace. 1997. Integral membrane proteins of the nu-
clear envelope are dispersed throughout the endoplasmic reticulum during
mitosis. J. Cell Biol. 137:1199–1210.
Ye, O., and H.J. Worman. 1996. Interaction between an integral protein of the
nuclear envelope inner membrane and human chromodomain proteins ho-
molgous to Drosophila HP1. J. Biol. Chem. 271:14653–14656.
Yen, A., and A.B. Pardee. 1979. Role of nuclear size in cell growth initiation.
Science. 204:1315–1317.
Yuan, J., G. Simos, G. Blobel, and S.D. Georgatos. 1991. Binding of lamin A to
polynucleosomes. J. Biol. Chem. 266:9211–9215.
Zhang, C., Jenkins, H., Goldberg, M.W., Allen, T.D., and C.J. Hutchison. 1996.
Nuclear lamina and nuclear matrix organization in sperm pronuclei assem-
bled in Xenopus egg extract. J. Cell Sci. 109:2275–2286.